A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study.
Phase of Trial: Phase III
Latest Information Update: 28 Aug 2014
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms BE-LOW
- 03 Jul 2012 Planned number of patients changed from 384 to 462 as reported by European Clinical Trials Database.
- 02 Feb 2012 Additional location (Mexico) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Actual patient number (669) added as reported by ClinicalTrials.gov.